Skip to main content

Kurita establishes R&D base

Kurita has established a new R&D base called the Kurita Innovation Hub (KIH) at Akishima city in Tokyo. Covering about 38,400 m2 and employing 400, this comprises two buildings: the Technology Innovation Centre and the Technical Education Centre.

Japanese firms form API JV

Seven Japanese firms have come together to create a joint venture that will develop technology for continuous manufacturing (CM) of APIs and intermediates and a CDMO business using it. Pharmira, whose name comes from ‘pharmaceutical’ and the Japanese word for ‘future’, employs 27 and is based at Amagasaki.

PharmaZell-Novasep merger complete

Following negotiations begun in September 2021, PharmaZell, a German-based supplier of speciality APIs, and Novasep, a CDMO focused on complex small molecules and ADCs, have closed their merger under the majority ownership of Bridgepoint Group. Former PharmaZell CEO Dr Sylke Hassel (pictured) will be CEO, while former Novasep CEO Michel Spagnol has joined the board of directors.

Perstorp to double carboxylic acids

Perstorp plans to roughly double its carboxylic acids capacity by 2024, by adding a second 70,000 tonnes/year facility at its main site in Stenungsund, Sweden. Like the original unit, this will produce acids from C3 to C9 chemistry and will be fully integrated into the company’s oxo production platform.

Heraeus improves lignin conversion

In collaboration with Johannes Kepler University Linz, Heraeus Precious Metals has developed and applied for a patent on an industrial precious metal catalyst for efficient lignin conversion. This is described as “highly suitable for the conversion of lignin to phenolic components on an industrial scale”.

AGC to expand in Spain

Japan’s AGC has announced plans for a new, 7,500 m2 building at the site of its AGC Pharma Chemicals Europe CDMO operation in Spain. Costing about $100 million, this is scheduled to begin operation in 1H 2024 and will add 30% to the site’s capacity. This comes on top of a 30% increase in capacity announced in April 2020.

New plant for WeylChem

The WeylChem Group has officially put a new multi-purpose custom manufacturing plant into operation at Lamotte in the Hauts-de-France region of France. This investment of around €7 million “strengthens our position as a versatile, high-quality partner with reliable European supply chains”, according to company president Uwe Brunk.

Subscribe to Current issue